Collegium Pharmaceutical (COLL) Gross Margin Growth (1y) (2017 - 2026)
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Gross Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 32.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 292.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -396.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -391.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -144.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 257.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 21.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -173.00 |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | -247.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -247.00 |
| Mar 31, 2026 | 583.00 |
| Dec 31, 2025 | 847.00 |
| Sep 30, 2025 | 94.00 |
| Jun 30, 2025 | -485.00 |
| Mar 31, 2025 | -836.00 |
| Dec 31, 2024 | -917.00 |
| Sep 30, 2024 | 202.00 |
| Jun 30, 2024 | 804.00 |
| Mar 31, 2024 | 964.00 |
| Dec 31, 2023 | 2,780.00 |
| Sep 30, 2023 | 1,242.00 |
| Jun 30, 2023 | 1,208.00 |
| Mar 31, 2023 | -444.00 |
| Dec 31, 2022 | 4,027.00 |
| Sep 30, 2022 | -1,216.00 |
| Jun 30, 2022 | -1,819.00 |
| Mar 31, 2022 | -548.00 |
| Dec 31, 2021 | -6,294.00 |
| Sep 30, 2021 | -238.00 |